Emerging markets have been making a comeback this year, returning around 26% in the past five years. One key trend to note is that many emerging market value ETFs have been outperforming general emerging marketAnalyst’s Disclosure:I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from ...

Core Insights - The article emphasizes the importance of delivering actionable insights that help investors navigate complex markets, particularly focusing on emerging markets and under-the-radar opportunities [1]. Group 1 - The company has a strong focus on global equities, especially in emerging markets [1]. - The goal is to provide deep insights that go beyond typical headlines [1]. - The content is published on various platforms, including Seeking Alpha, TipRanks, and GuruFocus [1].

Market Sensitivity to Tariffs - Emerging and frontier markets are sensitive to new tariff announcements, with Japan facing domestic pressure due to an upcoming election [1][2] - US is a crucial market for Asian countries, limiting their options in trade negotiations [3] - The US President hopes ongoing negotiations will be successful [4] Impact of a Weaker Dollar - A weaker dollar negatively impacts foreign investors with $17 trillion invested in US equities, particularly those denominated in Euro, Yen, Taiwanese dollar, or Singapore dollar [6] - From April 2011 to two years prior to the discussion, the US dollar index increased by 55%, but has since fallen by 20% [5] - The dollar's depreciation is causing losses for foreign investors, even if the S&P 500 is performing well [6] - Some money is flowing out of US equities from non-US investors and back into growth stocks, especially in Asia's tech sector [7] Potential Winners and Strategies - The US President aims to bring jobs back to America through tariffs [8] - Asian automakers have already moved some production to the US [9] - South Korean semiconductor producer SK Hynix might build a factory in the US, similar to TSMC [9] - The US is the largest exporter of services globally, requiring caution in trade actions to avoid affecting US companies selling services like software, finance, and intellectual property [10] - The current trade war is focused on goods, and the US President is navigating to prevent it from expanding into a services trade war [11]

Core Viewpoint - dLocal Limited has appointed Will Pruett as an Independent Board Member and member of the Audit Committee, effective July 1, 2025, to enhance the Board's guidance on growth and scalability [1][2][3] Group 1: Appointment Details - Will Pruett brings extensive expertise in capital markets and emerging markets, which will be crucial for dLocal's expansion and stakeholder value delivery [2][3] - Pruett has a notable background, including 16 years at Fidelity Investments managing various funds focused on Latin America and emerging markets, and prior experience at HSBC [2] - His appointment reflects dLocal's commitment to effective governance and diverse perspectives in driving growth strategies [3] Group 2: Board Changes - Mariam Toulan's term as Independent Director will conclude on June 30, 2025, and the company expresses gratitude for her contributions during her tenure [4] Group 3: Company Overview - dLocal operates a technology-first payments platform that connects global enterprise merchants with consumers in over 40 emerging market countries across Africa, Asia, and Latin America [5] - The "One dLocal" platform allows global companies to manage payments, pay-outs, and fund settlements without the complexity of multiple local entities and payment processors [5]

Core Insights - Emerging markets are crucial for Boston Scientific Corporation's (BSX) growth strategy, with a 9.8% year-over-year operational sales growth in Q1 2025 despite geopolitical challenges [1][8] - The medical device industry is experiencing strong growth opportunities in emerging markets, driven by trends such as preventive healthcare and digital health adoption [2] - Boston Scientific's sustained investment and localized strategies position it well to capture future growth in these high-potential regions [3] Emerging Market Performance - BSX's emerging market operations delivered robust sales growth of approximately 9.8% year over year in Q1 2025, supported by favorable economic trends and expanding healthcare infrastructure [1][8] - India’s medical device market is projected to grow from $15.35 billion in 2023 to $20.51 billion by 2029, reflecting a CAGR of 5.35% [2] - China and Brazil are highlighted as key markets due to their large populations and expanding economies, with Southeast Asian countries also gaining importance [2] Competitive Landscape - Competition in emerging markets is intense, with Abbott Laboratories and Medtronic actively expanding their global reach [4] - Abbott's Established Pharmaceuticals Division, focused on emerging markets, reported high single-digit organic growth in Q1 2025, driven by strong demand across Asia, Latin America, and the Middle East [5] - Medtronic generated nearly 49% of its revenues from international markets, with mid-single-digit growth in its emerging market business, particularly in India and Southeast Asia [6] Financial Performance - BSX shares have increased by 35.8% over the past year, outperforming the industry growth of 9.6% and the S&P 500's growth of 12.2% [7][8] - The company trades at a forward price-to-earnings ratio of 33.69, which is above the industry average of 21.73 [9] - The Zacks Consensus Estimate for BSX's earnings has been rising, indicating positive sentiment among analysts [10]